Saibia Third generation capillary heme detection reagent
Taiwan·Risk Class 2·SEBIA·Registered Oct 17, 2019 – Oct 17, 2029Active- Analysis ID
- d19ab70e316738317a9047b2dc4d8c39
- Customs Code
- DHA05603294401
- Manufacturer
- SEBIA
- Manufacturer Country
- France
- Authorized Representative
- ARQon Medtech Co., Ltd.
- Intended Use
- This product uses capillary electrophoresis to isolate normal heme (A, F and A2) in an alkaline buffer (pH 9.4) and detect the main variants of heme (S, C, E, and D). SUITABLE FOR SEBIA CAPILLARYS 3 INSTRUMENTS.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.7440 Heme electrophoresis analysis system
- Import Information
- import
- Registration Date
- Oct 17, 2019
- Expiry Date
- Oct 17, 2029
Top companies providing products similar to "Saibia Third generation capillary heme detection reagent"
Recently registered similar products
Access comprehensive regulatory information for Saibia Third generation capillary heme detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d19ab70e316738317a9047b2dc4d8c39 and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including SEBIA, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.